Renal dialysis equipment is intended to provide an artificial replacement for lost kidney function due to renal failure. Vascular Access devices for Hemodialysis include AV Fistula Needles, Grafts, Vascular Covered Stents, and Hemodialysis Catheters. GlobalData uses proprietary data and analytics to provide a comprehensive report on the vascular access devices for hemodialysis market in Taiwan. Buy the latest report here.

In 2022, GlobalData’s Market Model methodology determined that the leading player in the vascular access devices for hemodialysis market in Taiwan was B. Braun Melsungen followed by Baxter International, Becton Dickinson and Co, Fresenius SE & Co, Medtronic and W. L. Gore & Associates.

Understanding market size can be crucial to evaluate opportunities and make informed decisions about market entry and exit. Medical device companies can identify attractive segments in respective markets as well as develop marketing strategies based on forecasts for those segments.

Fistula needles are used to surgically create a direct connection between an artery and a vein resulting in the formation of a large blood vessel with an increased blood flow, providing access for hemodialysis. Grafts are strong artificial tubes inserted by surgeons underneath the skin of the patient’s forearms, upper arms or thigh. Vascular Covered Stent is an expandable, flexible, metal (nitinol) tube-shaped device (stent) that is covered with a material called expanded polytetrafluoroethylene (ePTFE). Hemodialysis catheters are intended for exchanging blood from the patient to and from the hemodialysis machine.

The vascular access devices for hemodialysis market in Taiwan can expand or contract due to a variety of reasons including population demographics, disease incidence and prevalence, macroeconomic issues, and geopolitical considerations. Disruption to a market could be caused by a sudden, unexpected change in these factors, but it could also be driven by changes in clinical practice, leading to a change in diagnosis or treatment of patients, as part of a process to generally improve medical practice.

For the latest analysis of the market size vascular access devices for hemodialysis in Taiwan, buy the report here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s Medical Intelligence Center Market Models are the gold standard of medical device market valuation, company share estimation and market trend forecasting. GlobalData uses a patient-based forecast model or installed base methodology to determine the market size for therapeutic indications and capital equipment expenditures. Estimates are based on a number of sources, including primary research—KOL and industry contact interviews—and secondary research, such as company reports, press releases, published articles, proprietary databases, and general news media.